Forced expiratory volume in 1 second (FEV1) >= 40% of predicted (corrected or uncorrected for hemoglobin per institutional standards)
Patients must have postoperative predicted forced expiratory volume (FEV) > 35% prior to surgery obtained within 28 days prior to step 2 registration
Pulmonary function forced expiratory volume in 1 second (FEV1) >= 50% of predicted
Chronic obstructive pulmonary disease with a forced expiratory volume in 1 second (FEV1) is less than (<) 50 % of predicted normal
Subject has known chronic obstructive pulmonary disease (COPD) with a forced expiratory volume in 1 second (FEV1) < 50% of predicted normal\r\n* Note that FEV1 testing is required for patients suspected of having COPD and subjects must be excluded if FEV1 < 50% of predicted normal
Participants with unilateral pleural effusion are eligible if they fulfill both of the following: (a) New York Heart Association (NYHA) Class 1; (b) Global initiative for obstructive lung disease (GOLD) test level 1 (forced expiratory volume in 1 second [FEV1]/ forced vital capacity [FVC] less than [<] 0.7 and FEV1 greater than or equal to [>=] 80 percent [%] predicted after inhaled bronchodilator)
PFTs including forced expiratory volume in 1 second (FEV1) within 26 weeks prior to registration; for FEV1, the best value obtained pre- or post-bronchodilator must be >= 0.8 liters/second or >= 50% predicted
All patients must have an forced expiratory volume in 1 second (FEV1) >= 700cc
Forced expiratory volume in 1 second (FEV1) > 65% of prediction for those patients with extensive pulmonary metastases or chronic pulmonary disease history
Documented forced expiratory volume in 1 second (FEV1) of less than or equal to 50% predicted in patients with clinical symptomatology
Uncontrolled asthma (defined as having 3 or more of the following features of partially controlled asthma within 28 days prior to starting study treatment: Daytime symptoms more than twice per week, any limitation of activities, any nocturnal symptoms/awaking, need for reliever/rescue inhaler more than twice per week, or known lung function [peak expiratory flow (PEF) or forced expiratory volume in 1 second (FEV1)] without administration of a bronchodilator that is < 80% predicted or personal best [if known]).
Known severe chronic obstructive pulmonary disease or asthma defined as forced expiratory volume (FEV1) in 1 second less than < 60% of expected
Patients who have obstructive or restrictive pulmonary disease and have a documented FEV1 (forced expiratory volume in 1 second) of ? 60%
Severe obstructive airway disease defined by forced expiratory volume at one second (FEV1) < 50%
Forced expiratory volume in 1 second (FEV1) > 1.0 L
Subject has known chronic obstructive pulmonary disease (COPD) with a forced expiratory volume in 1 second (FEV1) < 50% of predicted normal. NOTE: FEV1 testing is required for patients suspected of having COPD and subjects must be excluded if FEV1 < 50% of predicted normal
Patients with unstable or severe intercurrent medical conditions such as severe heart (New York Heart Association class 3 or 4) or lung (forced expiratory volume in 1 second [FEV1] < 50%) disease, uncontrolled diabetes mellitus
Known chronic obstructive pulmonary disease (COPD) with a forced expiratory volume in 1 second (FEV1) <50% of predicted normal. Note that FEV1 testing is required for subjects suspected of having COPD and subjects must be excluded if FEV1 is <50% of predicted normal.
Uncontrolled asthma (defined as having 3 or more of the following features of partially controlled asthma within 28 days prior to starting study treatment: daytime symptoms more than twice per week, any limitation of activities, any nocturnal symptoms/awaking, need for reliever/rescue inhaler more than twice per week, or known lung function [peak expiratory flow (PEF) or forced expiratory volume in 1 second (FEV1)] without administration of a bronchodilator that is < 80% predicted or personal best [if known])
Forced expiratory volume in 1 second (FEV1) >= 30% of predicted postoperative (ppoFEV1, as if patient underwent a pneumonectomy)
Adequate cardiopulmonary reserve defined as follows as assessed within 4 months of study entry:\r\n* Predicted postoperative forced expiratory volume FEV1 > 1L\r\n* Normal left ventricular function (ejection fraction EF ? 45%) and right ventricular function\r\n* No pulmonary hypertension noted on preoperative transthoracic echocardiography
Pre-treatment pulmonary function tests (PFTs), collected =< 90 days prior to enrollment, must show forced expiratory volume in one second (FEV1) > 60% of predicted
Diffusing capacity divided by the alveolar volume (DDLCO/VA) and forced expiratory volume (FEV) â€“ 1.0 > 50% of predicted on pulmonary function tests
Forced expiratory volume in 1 second (FEV1) > 50%
Forced expiratory volume in 1 second (FEV1) >= 50%
Unstable or severe intercurrent medical conditions such as severe heart (New York Association class 3 or 4) or lung (forced expiratory volume in 1 second [FEV1] < 50%) disease, uncontrolled diabetes mellitus
Forced expiratory volume in 1 second (FEV1) >= 50% of expected corrected for hemoglobin and/or volume
Forced expiratory volume in one second (FEV1) < 50% (corrected for hemoglobin)
FEV1 (forced expiratory volume in 1 second) >= 50% predicted
Forced expiratory volume in 1 second (FEV1) > 65%
Patients with clinically significant pulmonary dysfunction, as determined by medical history and physical exam should undergo pulmonary function testing; those with a forced expiratory volume in one second (FEV1) of < 50 % of predicted will be excluded
Forced expiratory volume in one second (FEV1) >= 50% of expected, corrected for hemoglobin
Forced expiratory volume in 1 second (FEV1) > 65% of predicted within 6 months of lymphodepletion (Turnstile II) or
Forced expiratory volume in one second (FEV1) >= 50%
Forced expiratory volume in one second (FEV1) >= 50%
Adequate lung function indicated by forced expiratory volume at 1 second (FEV1) >= 1 L is required
For patients enrolled post-P/D, only: forced expiratory volume in 1 second (FEV1) >= 35% (corrected for Hgb) (Note: patients enrolled prior to P/D will have pulmonary function tests (PFTs) repeated pre-IMRT; if this criteria is not met, they will be removed from study)
Forced expiratory volume in one second (FEV1) 40% of predicted or 3 standard deviations (SD) below normal
Forced expiratory volume in one second (FEV1) >= 50% of expected value obtained within 90 days of enrollment\r\n* Note: For children who are unable to cooperate for positron emission tomography (PFT)s, the criterion is: No evidence of dyspnea at rest, no exercise intolerance, and no requirement for supplemental oxygen therapy
Forced expiratory volume in one second (FEV1) >= 50%
FEV1 (forced expiratory volume in the first second) >= 50% of predicted, corrected for volume and hemoglobin
Forced expiratory volume in 1 second (FEV1) > 60% by pulmonary function test
With known chronic obstructive pulmonary disease (COPD) with a forced expiratory volume in 1 second (FEV1) <50% of predicted normal. Note: FEV1 testing is required for participants suspected of having COPD and participants must be excluded if FEV1 is <50% of predicted normal.
Subject has known chronic obstructive pulmonary disease (COPD) with a forced expiratory volume in 1 second (FEV1) < 50% predicted normal; Note that FEV1 testing is required for patients suspected of having COPD and subjects must be excluded if FEV < 50%
Subject has known chronic obstructive pulmonary disease (COPD) with a forced expiratory volume in 1 second (FEV1) < 50% of predicted normal. NOTE: FEV1 testing is required for patients suspected of having COPD and subjects must be excluded if FEV1 < 50% of predicted normal
Pulmonary disease: forced expiratory volume in 1 second (FEV1) < 60% predicted
> 50% forced expiratory volume of the lung in 1 second (FEV1), if presence of pleural effusion due to metastatic disease > 40% corrected FEV1 is acceptable (within 28 days of treatment start)
Forced expiratory volume >= 1.0 L or >= 40% of predicted with or without bronchodilators by pulmonary function testing
Forced expiratory volume in 1 second (FEV1) >= 50% of predicted value
Forced expiratory volume in one second (FEV1) >= 50% predicted
Forced expiratory volume in one second (FEV1) >= 50% of predicted value (corrected to serum hemoglobin)
Adequate pulmonary function based on the following pulmonary function tests done within 8 weeks of registration:\r\n* Forced expiratory volume (FEV)1 at least 2.0 liters; if less than 2.0 liters, the predicted post-resection FEV1 must be at least 0.8 liters \r\n* Diffusion capacity should be >= 50% predicted
Forced expiratory volume in 1 second (FEV1) < 50% of normal
Known chronic obstructive pulmonary disease with a forced expiratory volume in 1 second (FEV1) less than (<)50 percent (%) of predicted normal
Has chronic obstructive pulmonary disease (COPD) with a forced expiratory volume in 1 second (FEV1) 50% of predicted normal
Patients must have pulmonary function tests (PFTs) including forced expiratory volume in 1 second (FEV1) within 84 days prior to registration; for FEV1, the best value obtained pre- or post-bronchodilator must be >= 1.2 liters/second and/or >= 50% predicted
Forced expiratory volume in one second (FEV1) with >= 1200 cc or >= 50% predicted
Forced expiratory volume of the lung in 1 second (FEV1) >= 40% predicted
Known chronic obstructive pulmonary disease (COPD) with a forced expiratory volume in 1 second (FEV1) <50% of predicted normal or known moderate or severe persistent asthma within the past 2 years, or uncontrolled asthma of any classification
Patients who would be receiving SBRT for lung tumors who are known or suspected by the treating radiation oncologist to have compromised lung function must have a documented forced expiratory volume in 1 second (FEV1) >= 1 L
Forced expiratory volume in one second (FEV-1) >= 50%
Has known chronic obstructive pulmonary disease with a forced expiratory volume in 1 second (FEV1) < 50% of predicted normal (note that FEV1 testing is required for subjects suspected of having chronic obstructive pulmonary disease and subjects must be excluded if FEV1 < 50% of predicted normal)
Forced expiratory volume in 1 second (FEV1) >= 50%
Forced expiratory volume in 1 second (FEV1) >= 50%
Forced expiratory volume in one second (FEV1) testing required only if symptomatic or prior known impairment
Forced expiratory volume in 1 second (FEV1) >= 1 liter
Forced expiratory volume in 1 second (FEV1) >= 2.0 liters or >= 75% of predicted for height and age; (pulmonary function tests [PFTs] are required for patients over 50 or with significant pulmonary or smoking history)
Patients be able to undergo VATS resection as defined below:\r\n* Preoperative forced expiratory volume in 1 second (FEV1) >= 40% predicted OR\r\n* Post-operative predicted FEV1 >= 0.8 l\r\n* Mercury (Hg) >= 8.0\r\n* No evidence of coronary ischemia on cardiac evaluation per institutional standard (ie. cardiology evaluation, stress test, etc.)
Forced expiratory volume in one second (FEV1) must be >= 1.0 L
Forced expiratory volume (FEV) < 30% predicted
Forced expiratory volume in 1 second (FEV1) > 2.0 liters or > 75% of predicted for height and age; pulmonary function tests (PFTs) are required for patients over 50 years old or with significant pulmonary or smoking history
Forced expiratory volume (FEV) =< 1.2 L/s
Forced expiratory volume of the lung in one second (FEV1) > 40% of predicted at the screening visit
Forced expiratory volume in one second (FEV1) >= 50% of expected corrected for hemoglobin
Current severely impaired lung function (i.e., forced expiratory volume in 1 second [FEV1] < 1 liter)
Forced expiratory volume in 1 second (FEV1) >= 40% of predicted
Forced expiratory volume (FEV) 1 > 2.0 liters or > 75% of predicted for height and age (pulmonary function test [PFTs] are required for patients over 50 years old or with significant pulmonary or smoking history)
Forced expiratory volume in one second (FEV1) >= 40%; no symptomatic pulmonary disease
History of severe chronic obstructive pulmonary disease (COPD) defined as a forced expiratory volume in 1 second (FEV1) < 50% of predicted
Advanced pulmonary disease as assessed by clinical symptoms of shortness of breath or known forced expiratory volume in 1 second (FEV1) < 1
Patients with severe chronic obstructive pulmonary disease (COPD) defined as a forced expiratory volume in one second (FEV1) < 50%
Severe obstructive lung disease (forced expiratory volume in 1 second [FEV1]/forced vital capacity [FVC] < 70% post bronchodilator and forced expiratory volume in 1 second < 30% predicted)
FEV1 (forced expiratory volume in 1 second) >= 50% predicted
A forced expiratory volume in one second (FEV1) of 60% or greater, a diffusion capacity of 50% or greater, and a oxygen partial pressure (PO2) of 80 mm mercury (Hg) or greater on pulmonary function testing
Forced expiratory volume in 1 second (FEV1) > 800 cc
Chronic obstructive pulmonary disease (COPD), Global Initiative for Chronic Obstructive Lung Disease (GOLD) II or greater (defined as forced expiratory volume in 1 second [FEV1]/ forced vital capacity [FVC] < 70% and FEV1 % predicted < 80%)
Forced expiratory volume at one second (FEV1): best value obtained pre- or post-bronchodilator must be ? 1.0 liters/second or > 50% predicted value
Subject has known chronic obstructive pulmonary disease (COPD) with a forced expiratory volume in 1 second (FEV1) < 50% predicted normal; Note that FEV1 testing is required for patients suspected of having COPD and subjects must be excluded if FEV1 < 50%
